Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2025-08-08 00:00:00 ET · period of report 2025-08-07 · accession 0001415889-25-021351 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-08 | 2025-08-07 | MIRM | Howe Jolanda | SVP, Gbl Ctrl | M - OptEx | $6.27 | +10.0K | 12.4K | +412% | +$62.7K |
| D | 2025-08-08 | 2025-08-07 | MIRM | Howe Jolanda | SVP, Gbl Ctrl | S - Sale+OE | $58.00 | -10.0K | 2,426 | -80% | -$580.0K |
| D | 2025-08-08 | 2025-08-07 | MIRM | Howe Jolanda | SVP, Gbl Ctrl | M - OptEx | $0.00 | -10.0K | 40.0K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-07 | M | A | 10,000 | $6.27 | 12,426 | D | — | — | |
| 2 | Common | Common Stock | 2025-08-07 | S | D | 10,000 | $58.00 | 2,426 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2025-08-07 | M | D | 10,000 | $0.00 | 40,000 | D | $6.27 · — to 2029-05-13 | 10,000 Common Stock | (F2) The stock option is fully vested. |